HRO

Harrow

HROW • NASDAQ

Harrow is a medical - pharmaceuticals company in the healthcare sector trading on NASDAQ, led by CEO Mark L. Baum, with a market cap of $1.4B.

Market Cap$1.4B
Employees382.0
CEOMark L. Baum
CountryUnited States of America
Healthcare
Medical - Pharmaceuticals
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Income StatementBalance SheetCash FlowBusiness Segments

Financials

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
HRO

Harrow FAQ

Common questions about Harrow

Harrow is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $51.9M.

Harrow has approximately 382 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.